Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Solventum Corp (SOLV)
The Solventum share price today is 71.65, view NYSE SOLV stock exchange data. Track the latest Solventum share price with real-time updates on SOLV stock performance including market cap, day range, 52-week range and dividend yield. Access SOLV charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
70.51
72.26
52 wk Range
62.38
88.20
SOLV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
70.5172.26
52 wk Range
62.3888.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SOLV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
81.08
Upside
+13.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
10 analysts have revised their earnings upwards for the upcoming period
- Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Solventum Corp For: 5 May
- Investing.com
- Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Solventum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
5 Buy
6 Hold
2 Sell
Ratings:
13 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 81.08
(+13.17% Upside)
Solventum Corp Earnings Call Summary for Q1/2026
- Q1 EPS of $1.48 beat forecast of $1.34 by 10.45%; revenue reached $2.0B with 2.1% organic growth despite portfolio adjustments.
- Gross margin improved 80 basis points year-over-year to 56.4%; successful integration of Acera Surgical acquisition boosted performance.
- Company forecasts Q2 EPS of $1.70 and full-year EPS of $6.58; plans to launch nearly 20 new products over next two years.
- Stock rose 0.1% to $67.51 in aftermarket trading; tariff and inflationary pressures remain key challenges to profitability.
Last Updated: 06-05-2026, 03:28 am
Read Full TranscriptEarnings
Latest Release
05-05-2026
EPS / Forecast
1.48 / 1.34
Revenue / Forecast
2.01B / --
Compare SOLV to Peers and Sector
Metrics to compare | SOLV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOLVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.7x | 41.4x | −0.6x | |
PEG Ratio | 0.03 | −0.18 | 0.00 | |
Price/Book | 2.5x | 2.9x | 2.6x | |
Price / LTM Sales | 1.5x | 2.4x | 3.2x | |
Upside (Analyst Target) | 15.5% | 17.2% | 48.1% | |
Fair Value Upside | Unlock | 29.6% | 5.8% | Unlock |
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Solventum (SOLV) Share Price Today?
The Solventum share price today is 71.65.
What is the current Solventum (SOLV) share price and day range?
As of 08-05-2026, the Solventum share price is 71.65, with a previous close of 70.99. The share price has ranged from 70.51 to 72.26 today, while the 52-week range spans from 62.38 to 88.20.
What Is the Solventum Market Cap?
As of today, Solventum market cap is 12.29B.
What Is the Solventum (SOLV) Share Price Target?
The average 12-month share price target for Solventum is 81.08, with a high estimate of 100 and a low estimate of 60. 5 analysts recommend buying, while 2 suggest selling, with an overall rating of Neutral and +13.17% Upside potential.
What Is Solventum's Earnings Per Share (TTM)?
The Solventum EPS (TTM) is 8.16.
When Is the Next Solventum Earnings Date?
Solventum will release its next earnings report on 06-08-2026.
From a Technical Analysis Perspective, Is SOLV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Solventum Trade On?
Solventum is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Solventum?
The stock symbol for Solventum is "SOLV."
How Many Times Has Solventum Stock Split?
Solventum has split 0 times.
How Many Employees Does Solventum Have?
Solventum has 20584 employees.
What Is the SOLV Premarket Price?
SOLV's last pre-market stock price is 71.25. The pre-market share volume is 540.00, and the stock has changed by 0.26, or 0.37%.
What Is the SOLV After Hours Price?
SOLV's last after hours stock price is 72.78, the stock has changed by 1.13, or 1.58%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.